EMMAUS LIFE SCIENCES, INC.: research and development expense
Research and development expense for EMMAUS LIFE SCIENCES, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All EMMAUS LIFE SCIENCES, INC. financial histories
What this measure means
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
Exact concept: us-gaap:ResearchAndDevelopmentExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2018-01-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 313,000 | USD | 2026-03-31 | 10-K · 0001193125-26-132925 |
| 2024-01-01 | 2024-12-31 | 657,000 | USD | 2026-03-31 | 10-K · 0001193125-26-132925 |
| 2023-01-01 | 2023-12-31 | 1,189,000 | USD | 2025-04-14 | 10-K · 0000950170-25-053744 |
| 2022-01-01 | 2022-12-31 | 1,725,000 | USD | 2024-07-03 | 10-K · 0000950170-24-080918 |
| 2021-01-01 | 2021-12-31 | 4,110,000 | USD | 2023-03-31 | 10-K · 0000950170-23-011328 |
| 2020-01-01 | 2020-12-31 | 2,408,000 | USD | 2022-03-31 | 10-K · 0001564590-22-013054 |
| 2019-01-01 | 2019-12-31 | 2,183,000 | USD | 2021-08-10 | 10-K/A · 0001564590-21-042835 |
| 2018-01-01 | 2018-12-31 | 1,723,000 | USD | 2021-01-25 | 10-K · 0001564590-21-001977 |
Related financial histories
- EMMAUS LIFE SCIENCES, INC.: total assets
- EMMAUS LIFE SCIENCES, INC.: total liabilities
- EMMAUS LIFE SCIENCES, INC.: stockholders equity
- EMMAUS LIFE SCIENCES, INC.: cash and cash equivalents
- EMMAUS LIFE SCIENCES, INC.: net income or loss
- EMMAUS LIFE SCIENCES, INC.: operating cash flow
- EMMAUS LIFE SCIENCES, INC.: capital expenditure payments
- EMMAUS LIFE SCIENCES, INC.: contract revenue excluding tax
- EMMAUS LIFE SCIENCES, INC.: financing cash flow
- EMMAUS LIFE SCIENCES, INC.: investing cash flow
- EMMAUS LIFE SCIENCES, INC.: retained earnings or deficit
- EMMAUS LIFE SCIENCES, INC.: basic weighted-average shares
- EMMAUS LIFE SCIENCES, INC.: diluted weighted-average shares
- EMMAUS LIFE SCIENCES, INC.: basic earnings per share
- EMMAUS LIFE SCIENCES, INC.: diluted earnings per share
- EMMAUS LIFE SCIENCES, INC.: income tax expense or benefit
- EMMAUS LIFE SCIENCES, INC.: net property, plant and equipment
- EMMAUS LIFE SCIENCES, INC.: share-based compensation expense
- EMMAUS LIFE SCIENCES, INC.: operating income or loss
- EMMAUS LIFE SCIENCES, INC.: current assets
- EMMAUS LIFE SCIENCES, INC.: interest expense
- EMMAUS LIFE SCIENCES, INC.: current liabilities
- EMMAUS LIFE SCIENCES, INC.: current accounts payable
- EMMAUS LIFE SCIENCES, INC.: net current accounts receivable
- EMMAUS LIFE SCIENCES, INC.: operating expenses
- EMMAUS LIFE SCIENCES, INC.: net inventory
- EMMAUS LIFE SCIENCES, INC.: gross profit
- EMMAUS LIFE SCIENCES, INC.: cost of revenue
Inspect the source
- Entity
- EMMAUS LIFE SCIENCES, INC. / CIK 0000822370
- Captured
- 2026-09-19T15:07:32.070Z
- SEC response SHA-256
17a0e00ebefc084a552aa5eee008f384d4ffcc14ecda3109b6fc4e736255806b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000822370.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))